Abstract:Abstract BACKGROUND AND AIMS Patients with inflammatory bowel disease (IBD), Crohn’s disease (CD), and ulcerative colitis (UC) have been shown to be at up to a 40% increased risk of developing Parkinson’s disease (PD), a progressive neurodegenerative disorder. Even though a genetic link between IBD and PD was established through shared causal mutations in the LRRK2 gene, it cannot fully explain the observed comorbidity. The goal of this study was to further explore the genetic overlap between these two diseases. METHODS The polygenic risk scores (PRS), representing estimated genetic determinants for IBD, CD, UC, and PD from previously reported respective genome-wide association studies, were computed using a linear combination of the estimated effects across multiple disease-associated variants in the Parkinson’s Progression Markers Initiative (PPMI, www.ppmi-info.org/data) cohort consisting of 413 PD cases and 195 healthy controls (HC) of predominantly European ancestry. We applied a generalized linear regression model to determine the relationship between IBD-related PRS and PD status while adjusting for sex, age, ethnicity, and principal components (PC1-5). A gene-set enrichment analysis was then conducted using Enrichr to examine the biological pathways associated with the genes regulated by variants intersecting between PRS-IBD and PRS-PD in various tissues relevant to IBD and PD (whole blood, visceral adipose fat, brain, and skeletal muscles). RESULTS As expected, PRS-PD was significantly elevated in PD patients (odds ratio (OR) 1.76 [95% confidence interval 1.39-2.26], adjusted p=5.34e-06). We also found that PRS-IBD, PRS-CD, and PRS-UC were significantly positively associated with PD case status (OR 1.37 [1.07-1.76], adjusted p=0.01, OR 1.46 [1.15-1.87], adjusted p=0.002, OR 1.36 [1.05-1.76], adjusted p=0.02, respectively, Figure 1). Gene-set enrichment analysis of the intersecting genes between PRS-IBD and PRS-PD across the 4 different relevant tissue types consistently identified the pathways implicating susceptibility to immune-mediated diseases and infections and immune cell differentiation and processing (Figure 2). CONCLUSION These results further support the genetic link between IBD and PD and emphasize the role of immunity, particularly pertaining to the adaptive immune system in the pathogenesis of both diseases. This is in line with the established role of autoimmunity in IBD etiology and is consistent with recent studies implicating the autoimmune system in PD development. Moreover, our findings suggest that PRS-IBD could serve as an early biomarker of PD and help stratify high-risk IBD patients for future PD prevention interventions.

The landscape of rare genetic variation associated with inflammatory bowel disease and Parkinson's disease comorbidity

GENETIC OVERLAP BETWEEN INFLAMMATORY BOWEL DISEASE AND PARKINSON’S DISEASE IMPLICATES THE ROLE OF ADAPTIVE IMMUNE RESPONSE IN THEIR COMORBIDITY

Clinical and Functional Evidence for the Pathogenicity of the LRRK2 P.arg1067gln Variant

Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson's disease

LRRK2; Communicative Role in the Treatment of Parkinson’s Disease and Ulcerative Colitis Overlapping

Gene-based Burden Analysis of Damaging Private Variants in PRKN, PARK7 and PINK1 in Parkinson's Disease Cohorts of European Descent

Analysis of Rare Variants of Autosomal‐dominant Genes in a Chinese Population with Sporadic Parkinson’s Disease

Transcriptomics and weighted protein network analysis of the LRRK2 protein interactome reveal distinct molecular signatures for sporadic and LRRK2 Parkinson’s Disease

Functional Variants in the LRRK2 Gene Confer Shared Effects on Risk for Crohn’s Disease and Parkinson’s Disease

LRRK2 G2019S mutation incites increased cell-intrinsic neutrophil effector functions and intestinal inflammation in a model of infectious colitis

Investigating the molecular mechanisms underlying the co-occurrence of Parkinson's disease and inflammatory bowel disease through the integration of multiple datasets

Genome-wide epistasis analysis reveals significant epistatic signals associated with Parkinson's disease risk

Targeting Specific Kinase Substrates Rescues Increased Colitis Severity Induced by the Crohn’s Disease-Linked LRRK2-N2081D Variant

Comprehensive Analysis and Experimental Validation of the Parkinson's Disease Lysosomal Gene ACP2 and Pan-cancer

Targeting Specific Kinase Substrates Rescues Increased Colitis Severity Induced by the Crohn's Disease-Linked LRRK2-N2081D Variant

Exploring Environmental Modifiers of LRRK2-Associated Parkinson’s Disease Penetrance through Exposomics and Metagenomics of Household Dust

Rare Variants Analysis of Lysosomal Related Genes in Early-Onset and Familial Parkinson's Disease in a Chinese Cohort

Expanding Parkinson’s disease genetics: novel risk loci, genomic context, causal insights and heritable risk

Mutant LRRK2 exacerbates immune response and neurodegeneration in a chronic model of experimental colitis

Quantitative Assessment of the Effect of LRRK2 Exonic Variants on the Risk of Parkinson’s Disease: A Meta-Analysis

Exploration of the Common Gene Characteristics and Molecular Mechanism of Parkinson’s Disease and Crohn’s Disease from Transcriptome Data